Buying $100 In CI: If an investor had bought $100 of CI stock 15 years ago, it would be worth $929.38 today based on a price ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Do these positive trends make Citigroup stock a buy now? Citigroup has undergone a significant transformation in recent years ...

Guggenheim has reaffirmed its buy rating on The Cigna Group, setting a target price of $388, making investors grin. The Cigna ...

UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390. Rice shared his views ...

Guggenheim analyst Jason Cassorla maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $388.00. The company’s shares closed yesterday at $31 ...

Hims & Hers Health, Inc. navigates strong growth and partnerships despite rising competitive risks. Click here to read an ...

Wall Street’s worries about a ballooning deficit that threatens America’s status as a safe haven were reflected in a $16 ...

HQH trades at an 8% discount to NAV, offering an attractive entry point compared to peers, despite recent price declines.

Trump signed an executive order to lower drug prices, which could hit pharmacy benefit managers (PBMs) hard. PBMs have come under scrutiny for opaque pricing practices. Mark Cuban calls PBMs a racket.

On May 15, Christopher Danely from Citi maintained a “Buy” rating on the stock with a price target of $110.00. A few days prior, J.P. Morgan analyst Harlan Sur maintained their bullish stance ...

Canaan (NASDAQ:CAN – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at Rosenblatt Securities in a research note issued on Thursday,Benzinga reports.